VENTYX BIOSCIENCES INC. - COMMON STOCK

Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress

23 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference

07 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis

06 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

19 ноя 2021 07:00:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update

17 ноя 2021 15:11:04 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 окт 2021 15:58:33 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering

20 окт 2021 19:38:40 Источник Nasdaq GlobeNewswire